𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Androgen receptor coregulators and their involvement in the development and progression of prostate cancer

✍ Scribed by Renée Chmelar; Grant Buchanan; Eleanor F. Need; Wayne Tilley; Norman M. Greenberg

Publisher
John Wiley and Sons
Year
2006
Tongue
French
Weight
318 KB
Volume
120
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The androgen receptor signaling axis plays an essential role in the development, function and homeostasis of male urogenital structures including the prostate gland although the mechanism by which the AR axis contributes to the initiation, progression and metastatic spread of prostate cancer remains somewhat enigmatic. A number of molecular events have been proposed to act at the level of the AR and associated coregulators to influence the natural history of prostate cancer including deregulated expression, somatic mutation, and post‐translational modification. The purpose of this article is to review the evidence for deregulated expression and function of the AR and associated coactivators and corepressors and how such events might contribute to the progression of prostate cancer by controlling the selection and expression of AR targets. © 2006 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Interaction of IGF signaling and the and
Interaction of IGF signaling and the androgen receptor in prostate cancer progression
✍ Jennifer D. Wu; Kathy Haugk; Libby Woodke; Peter Nelson; Ilsa Coleman; Stephen R 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 352 KB 👁 1 views

## Abstract The insulin‐like growth factor type I receptor (IGF‐IR) has been suggested to play an important role in prostate cancer progression and possibly in the progression to androgen‐independent (AI) disease. The term AI may not be entirely correct, in that recent data suggest that expression

Regulation of androgen receptor levels:
Regulation of androgen receptor levels: Implications for prostate cancer progression and therapy
✍ Kerry L. Burnstein 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB 👁 3 views

## Abstract Androgen deprivation has been the standard therapy for advanced and metastatic prostate cancer for over half a century, as prostate tumors are initially dependent on androgens for growth and survival. Unfortunately, in most patients undergoing androgen ablation, relapse (recurrent tumor

Androgen receptor: A key molecule in the
Androgen receptor: A key molecule in the progression of prostate cancer to hormone independence
✍ Mary-Ellen Taplin; Steven P. Balk 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

## Abstract Despite earlier detection and recent advances in surgery and radiation, prostate cancer is second only to lung cancer in male cancer deaths in the United States. Hormone therapy in the form of medical or surgical castration remains the mainstay of systemic treatment in prostate cancer.

Differential transactivation by the andr
Differential transactivation by the androgen receptor in prostate cancer cells
✍ Snoek, Robert; Bruchovsky, Nicholas; Kasper, Susan; Matusik, Robert J.; Gleave, 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB 👁 1 views

## BACKGROUND. The purpose of this study was to determine the contribution of different transactivating regions of the androgen receptor (AR) to the induction of androgen-regulated promoters in poorly (PC3 cells) and well-differentiated (LNCaP cells) prostate cancer cell lines. METHODS. PC3 and LN